- Release Date: 19/04/24 08:36
- Summary: Type D Response Submitted and Received by the US FDA
- Price Sensitive: Yes
- Download Document 157.42KB
- Forums
- ASX - By Stock
- PAR
- Ann: Type D Response Submitted and Received by the US FDA
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
4.76%
!
30.0¢

Ann: Type D Response Submitted and Received by the US FDA
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
-0.015(4.76%) |
Mkt cap ! $125.1M |
Open | High | Low | Value | Volume |
30.5¢ | 31.3¢ | 30.0¢ | $36.58K | 119.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 247795 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 60362 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 85722 | 0.305 |
20 | 260534 | 0.300 |
6 | 53169 | 0.295 |
12 | 247900 | 0.290 |
7 | 1025554 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 29205 | 6 |
0.315 | 19731 | 7 |
0.320 | 237816 | 9 |
0.325 | 4097 | 1 |
0.330 | 6200 | 3 |
Last trade - 10.40am 12/08/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |